[HTML] mdpi.com

[HTML][HTML] Clinical and regulatory concerns of biosimilars: a review of literature

V Halimi, A Daci, K Ancevska Netkovska… - International journal of …, 2020 - mdpi.com
Although biosimilars have been part of clinical practice for more than a decade, healthcare
professionals (HCPs) do not fully accept them. This is because of the perception that …
被引用次数：44 相关文章

Clinical and Regulatory Concerns of Biosimilars: A Review of Literature

V Halimi, A Daci, KA Netkovska, L Suturkova… - IJERPH, 2020 - ideas.repec.org
Although biosimilars have been part of clinical practice for more than a decade, healthcare
professionals (HCPs) do not fully accept them. This is because of the perception that …

Clinical and Regulatory Concerns of Biosimilars: A Review of Literature

V Halimi, A Daci, KA Netkovska, L Suturkova… - IJERPH, 2020 - econpapers.repec.org
Although biosimilars have been part of clinical practice for more than a decade, healthcare
professionals (HCPs) do not fully accept them. This is because of the perception that …

Clinical and Regulatory Concerns of Biosimilars: A Review of Literature

V Halimi, A Daci, KA Netkovska… - … and public health, 2020 - pubmed.ncbi.nlm.nih.gov
Although biosimilars have been part of clinical practice for more than a decade, healthcare
professionals (HCPs) do not fully accept them. This is because of the perception that …

Clinical and Regulatory Concerns of Biosimilars: A Review of Literature

V Halimi, A Daci, KA Netkovska… - … and Public Health, 2020 - search.proquest.com
Although biosimilars have been part of clinical practice for more than a decade, healthcare
professionals (HCPs) do not fully accept them. This is because of the perception that …
[PDF] semanticscholar.org

[PDF][PDF] Clinical and Regulatory Concerns of Biosimilars: A Review of Literature

V Halimi, A Daci, KA Netkovska… - Int. J. Environ. Res …, 2020 - pdfs.semanticscholar.org
Although biosimilars have been part of clinical practice for more than a decade, healthcare
professionals (HCPs) do not fully accept them. This is because of the perception that …

Clinical and Regulatory Concerns of Biosimilars: A Review of Literature.

V Halimi, A Daci, L Suturkova, ZU Babar… - … Research and Public …, 2020 - europepmc.org
Although biosimilars have been part of clinical practice for more than a decade, healthcare
professionals (HCPs) do not fully accept them. This is because of the perception that …

Clinical and Regulatory Concerns of Biosimilars: A Review of Literature

V Halimi, A Daci, KA Netkovska… - … Research and Public …, 2020 - pure.hud.ac.uk
Although biosimilars have been part of clinical practice for more than a decade, healthcare
professionals (HCPs) do not fully accept them. This is because of the perception that …
[PDF] researchgate.net

[PDF][PDF] Clinical and Regulatory Concerns of Biosimilars: A Review of Literature

V Halimi, A Daci, KA Netkovska… - Int. J. Environ. Res …, 2020 - researchgate.net
Although biosimilars have been part of clinical practice for more than a decade, healthcare
professionals (HCPs) do not fully accept them. This is because of the perception that …
[HTML] nih.gov

[HTML][HTML] Clinical and Regulatory Concerns of Biosimilars: A Review of Literature

V Halimi, A Daci, KA Netkovska… - … Research and Public …, 2020 - ncbi.nlm.nih.gov
Although biosimilars have been part of clinical practice for more than a decade, healthcare
professionals (HCPs) do not fully accept them. This is because of the perception that …